TrialBreast cancer research : BCR2019

Patterns of occurrence and implications of neratinib-associated diarrhea in patients with HER2-positive breast cancer: analyses from the randomized phase III ExteNET trial.

Joanne Mortimer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.